Aldesleukin Completed Phase 4 Trials for Renal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00006864Interleukin-2 in Treating Patients With Metastatic Kidney Cancer